Genetic alterations in lung cancers help select treatment

Multiplexed testing of lung cancer tumors identified genetic alterations that were helpful in selecting targeted treatments, a study has shown. Patients that received matched therapy for lung cancer lived longer than patients who did not receive directed therapy, although randomized clinical trials are required to determine if this treatment strategy improves survival.